FNAM - EVOLUTIONARY GENOMICS, INC.

0.0002
0.000   100.000%

Share volume: 2,000
Last Updated: 04-09-2025
Business Services/Services – Research, Development, Testing Labs: -0.07%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
-0.75%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.00
P/E Ratio 
N/A
DAY RANGE
$0.00 - $0.00
EPS 
N/A
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
$2,000
Company detail
CEO:
Region: US
Website: evolgen.com
Employees: 2
IPO year: 2011
Issue type:
Market: OTCM
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Evolutionary Genomics, Inc. engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance.

Recent news
loading